ArticleThe Journal of antibiotics2022

Evaluation of 2,6-difluoro-3-(oxazol-2-ylmethoxy)benzamide chemotypes as Gram-negative FtsZ inhibitors.

Jesus D Rosado-Lugo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.